Appel SH - Search Results

1

Amyotrophic lateral sclerosis: early predictors of prolonged survival.

Czaplinski A, Yen AA, Appel SH. Czaplinski A, et al. Among authors: appel sh. J Neurol. 2006 Nov;253(11):1428-36. doi: 10.1007/s00415-006-0226-8. Epub 2006 Jun 13. J Neurol. 2006. PMID: 16773270

2

Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease.

Goldknopf IL, Sheta EA, Bryson J, Folsom B, Wilson C, Duty J, Yen AA, Appel SH. Goldknopf IL, et al. Among authors: appel sh. Biochem Biophys Res Commun. 2006 Apr 21;342(4):1034-9. doi: 10.1016/j.bbrc.2006.02.051. Epub 2006 Feb 20. Biochem Biophys Res Commun. 2006. PMID: 16516157

3

Expanded autologous regulatory T-lymphocyte infusions in ALS: A phase I, first-in-human study.

Thonhoff JR, Beers DR, Zhao W, Pleitez M, Simpson EP, Berry JD, Cudkowicz ME, Appel SH. Thonhoff JR, et al. Among authors: appel sh. Neurol Neuroimmunol Neuroinflamm. 2018 May 18;5(4):e465. doi: 10.1212/NXI.0000000000000465. eCollection 2018 Jul. Neurol Neuroimmunol Neuroinflamm. 2018. PMID: 29845093 Free PMC article.

4

The Role of Regulatory T Lymphocytes in Amyotrophic Lateral Sclerosis.

Beers DR, Zhao W, Appel SH. Beers DR, et al. Among authors: appel sh. JAMA Neurol. 2018 Jun 1;75(6):656-658. doi: 10.1001/jamaneurol.2018.0043. JAMA Neurol. 2018. PMID: 29507936 No abstract available.

5

Serum C-Reactive Protein as a Prognostic Biomarker in Amyotrophic Lateral Sclerosis.

Lunetta C, Lizio A, Maestri E, Sansone VA, Mora G, Miller RG, Appel SH, Chiò A. Lunetta C, et al. Among authors: appel sh. JAMA Neurol. 2017 Jun 1;74(6):660-667. doi: 10.1001/jamaneurol.2016.6179. JAMA Neurol. 2017. PMID: 28384752 Free PMC article. Clinical Trial.

6

TDP-43 activates microglia through NF-κB and NLRP3 inflammasome.

Zhao W, Beers DR, Bell S, Wang J, Wen S, Baloh RH, Appel SH. Zhao W, et al. Among authors: appel sh. Exp Neurol. 2015 Nov;273:24-35. doi: 10.1016/j.expneurol.2015.07.019. Epub 2015 Jul 26. Exp Neurol. 2015. PMID: 26222336

7

Peripheral nerve inflammation in ALS mice: cause or consequence.

Kano O, Beers DR, Henkel JS, Appel SH. Kano O, et al. Among authors: appel sh. Neurology. 2012 Mar 13;78(11):833-5. doi: 10.1212/WNL.0b013e318249f776. Epub 2012 Feb 29. Neurology. 2012. PMID: 22377817 Free PMC article. No abstract available.

8

Transplantation of human bone marrow stem cells into symptomatic ALS mice enhances structural and functional blood-spinal cord barrier repair.

Garbuzova-Davis S, Haller E, Navarro S, Besong TE, Boccio KJ, Hailu S, Khatib M, Sanberg PR, Appel SH, Borlongan CV. Garbuzova-Davis S, et al. Among authors: appel sh. Exp Neurol. 2018 Dec;310:33-47. doi: 10.1016/j.expneurol.2018.08.012. Epub 2018 Aug 30. Exp Neurol. 2018. PMID: 30172620 Free PMC article.

9

Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS.

Liao B, Zhao W, Beers DR, Henkel JS, Appel SH. Liao B, et al. Among authors: appel sh. Exp Neurol. 2012 Sep;237(1):147-52. doi: 10.1016/j.expneurol.2012.06.011. Epub 2012 Jun 23. Exp Neurol. 2012. PMID: 22735487 Free PMC article.

10

Introduction to supplement: the current status of treatment for ALS.

Miller RG, Appel SH. Miller RG, et al. Among authors: appel sh. Amyotroph Lateral Scler Frontotemporal Degener. 2017 Oct;18(sup1):1-4. doi: 10.1080/21678421.2017.1361447. Amyotroph Lateral Scler Frontotemporal Degener. 2017. PMID: 28872909

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results